Zohreh Amoozgar

7PUBLICATIONS
48CO-AUTHORS
Molecular targetsNanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2025
Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma.

Shanmugarajan Krishnan, Somin Lee, Zohreh Amoozgar

|Sep 09, 2025
Tumor Microenvironment Responsive TPZ-Loaded Core-Shell Polymeric Nanoparticles for Selective Cancer Bioreductive Therapy.

Sajjad Alimohammadvand, Mohammad Shahpouri, Mohammad Amin Adili Aghdam

|Jan 22, 2025
Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma.

Jun Ren, Zohreh Amoozgar, Taylor P Uccello

|Jun 21, 2023
Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes.

Pin-Ji Lei, Ethel R Pereira, Patrik Andersson

|Mar 10, 2023
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice.

Xinyue Dong, Jun Ren, Zohreh Amoozgar

Pageof 2